Drägerwerk AG & Co. KGaA
DRWKFOTCHealthcare● Active
$111.58
+$0.00(+0.00%)
Market Cap$2.1B
P/E Ratio—
52W High$116.83
52W Low$67.276
Drägerwerk AG & Co. KGaA (DRWKF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DRWKF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$0.72
Est. $0.72 · +0.0%
Revenue
$0.87B
Est. $0.87B · -0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
✓ 2-Quarter EPS Beat Streak
DRWKF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | — | — | — | — | $0.94B | — |
| — Q2 FY2026 | Apr 30, 2026 | $0.72 | $0.72 | +0.0% | $0.87B | $0.87B | -0.0% |
| — Q1 FY2026 | Mar 24, 2026 | $5.86 | $5.86 | +0.0% | $1.34B | $1.34B | -0.2% |
| — Q4 FY2025 | Oct 29, 2025 | — | $2.24 | — | $0.98B | $1.14B | -14.3% |
| — Q3 FY2025 | Jul 29, 2025 | — | $0.71 | — | $0.92B | $0.73B | +25.8% |
| — Q2 FY2025 | Apr 30, 2025 | — | -$0.13 | — | $0.80B | $0.79B | +1.4% |
| — Q1 FY2025 | Jan 15, 2025 | — | $4.13 | — | $1.11B | — | — |
| — Q4 FY2024 | Oct 29, 2024 | — | $0.84 | — | $0.85B | $0.90B | -5.2% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026
EPS Actual
$0.72
EPS Est.
$0.72
EPS Surpr.
+0.0%
Revenue
$0.87B
Q1 FY2026
Mar 24, 2026
EPS Actual
$5.86
EPS Est.
$5.86
EPS Surpr.
+0.0%
Revenue
$1.34B
Q4 FY2025
Oct 29, 2025
EPS Actual
$2.24
EPS Est.
—
EPS Surpr.
—
Revenue
$0.98B
Q3 FY2025
Jul 29, 2025
EPS Actual
$0.71
EPS Est.
—
EPS Surpr.
—
Revenue
$0.92B
Q2 FY2025
Apr 30, 2025
EPS Actual
-$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
$0.80B
Q1 FY2025
Jan 15, 2025
EPS Actual
$4.13
EPS Est.
—
EPS Surpr.
—
Revenue
$1.11B
Q4 FY2024
Oct 29, 2024
EPS Actual
$0.84
EPS Est.
—
EPS Surpr.
—
Revenue
$0.85B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.62 | $0.62 | $0.62 | 1 |
| Q4 FY2025 | $4.99 | $4.99 | $4.99 | 1 |
| Q3 FY2025 | $1.92 | $1.92 | $1.92 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $1.2B | $1.2B | $1.2B | 1 |
| Q3 FY2026 | $0.9B | $0.9B | $0.9B | 1 |
| Q2 FY2026 | $0.8B | $0.8B | $0.8B | 1 |
| Q1 FY2026 | $0.8B | $0.8B | $0.8B | 1 |
| Q4 FY2025 | $1.1B | $1.1B | $1.1B | 1 |
| Q3 FY2025 | $0.8B | $0.8B | $0.8B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +0.0% | $111.05 | $111.05 | +0.00% |
| ▲ Q1 FY2026 | Mar 24, 2026 | +0.0% | $104.99 | $109.51 | +4.31% |
| — Q4 FY2025 | Oct 29, 2025 | — | $88.33 | $88.33 | +0.00% |
| — Q3 FY2025 | Jul 29, 2025 | — | $67.28 | $67.28 | +0.00% |
| — Q2 FY2025 | Apr 30, 2025 | — | $67.28 | $67.28 | +0.00% |
| — Q1 FY2025 | Jan 15, 2025 | — | $47.11 | $47.11 | +0.00% |
| — Q4 FY2024 | Oct 29, 2024 | — | $51.75 | $51.75 | +0.00% |
| — Q3 FY2024 | Jul 25, 2024 | — | $56.00 | $56.00 | +0.00% |
Q2 FY2026+0.00%
Report Date
Apr 30, 2026
EPS Beat/Miss
+0.0%
Price Before
$111.05
Price After
$111.05
Q1 FY2026+4.31%
Report Date
Mar 24, 2026
EPS Beat/Miss
+0.0%
Price Before
$104.99
Price After
$109.51
Q4 FY2025+0.00%
Report Date
Oct 29, 2025
EPS Beat/Miss
—
Price Before
$88.33
Price After
$88.33
Q3 FY2025+0.00%
Report Date
Jul 29, 2025
EPS Beat/Miss
—
Price Before
$67.28
Price After
$67.28
Q2 FY2025+0.00%
Report Date
Apr 30, 2025
EPS Beat/Miss
—
Price Before
$67.28
Price After
$67.28
Q1 FY2025+0.00%
Report Date
Jan 15, 2025
EPS Beat/Miss
—
Price Before
$47.11
Price After
$47.11
Q4 FY2024+0.00%
Report Date
Oct 29, 2024
EPS Beat/Miss
—
Price Before
$51.75
Price After
$51.75
Q3 FY2024+0.00%
Report Date
Jul 25, 2024
EPS Beat/Miss
—
Price Before
$56.00
Price After
$56.00
Avg Beat Reaction+2.15%
Beat Rate2 / 8 quarters
Largest Move+4.31% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DRWKF ends December
Drägerwerk AG & Co. KGaA (DRWKF) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $0.72 (in line with the analyst consensus of $0.72). DRWKF has beaten EPS estimates for 2 consecutive quarters. The next DRWKF earnings date is expected around September 1, 2026.
Each quarter, investors track DRWKF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DRWKF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DRWKF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DRWKF earnings · 4 questionsDrägerwerk AG & Co. KGaA's next earnings report is expected around September 1, 2026. DRWKF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DRWKF historically reports after market close (AMC).
DRWKF earnings datewhen is DRWKF earningsDRWKF next earnings datewhen does DRWKF report earningsDRWKF earnings calendar
▸ Source: FMP · Drägerwerk AG & Co. KGaA SEC filings · US GAAP · Drägerwerk AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026